Synthesis, antitubercular activity and pharmacokinetic studies of some Schiff bases derived from 1- alkylisatin and isonicotinic acid hydrazide (INH)

Archives of Pharmacal Research

Volumn 26, Issue 10, 2003, Pages 778-784

  Aboul Fadl, Tarek ^a,b   Mohammed, Faragany Abdel Hamid ^b   Hassan, Ehsan Abdel Saboor ^c  

^a ASSIUT UNIVERSITY   (Egypt)

^b Assiut University   (Egypt)

^c Assiut University Faculty of Medicine   (Egypt)

Author keywords

1 alkylisatin; Antimycobacterial; In vivo bioavailability; Lipophilicity; Relative bioavailability; Schiff bases

Indexed keywords

DRUG DERIVATIVE; ISATIN; ISONIAZID; SCHIFF BASE; TUBERCULOSTATIC AGENT;

ANIMAL; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; DRUG SCREENING; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS; ORAL DRUG ADMINISTRATION; RABBIT; SYNTHESIS;

ADMINISTRATION, ORAL; ANIMALS; ANTITUBERCULAR AGENTS; DRUG EVALUATION, PRECLINICAL; ISATIN; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; RABBITS; SCHIFF BASES;

EID: 30444439708     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02980020     Document Type: Article

References (26)

1. Brown, R. K., Snider, R. E., and Stevenson, M. D., Some indole derivatives tested for antitubercular activity. J. Org. Chem., 21, 261-262 (1956).
2. Buu-Hoi, N. P., Xuong, N. D., Nam, N. H., Binon, F., and Royer, R., Tuberculostatic hydrazides and their derivatives. J. Chem. Soc., 1358-1364 (1953).
3. Canetti, G., Rist, N., and Grosset, J., Measure de la sensibilite du bacille tuberculeux aux drogues antibacillaires par la methode des proportions. Rev. Tuber., 58, 111-114 (1983).
4. Conradi, R. A., Burton, P. S., and Borchardt, R. T., In Pliska, V., Testa, B. and Waterbeemd, H. (Eds.). Lipophilicity in Drug Action and Toxicology, A Series Monographs of Methods and Principles in Medicinal Chemistry. VCH. Wienheim; New york; Basel; Cambridge; Tokyo, Vol. 4, p. 233 (1996).
5. Daisley, R. W. and Shah, V. K., Synthesis and antibacterial activity of some 5-nitro-3-phenyliminoindole-2(3 H)-one and their N-Mannich bases. J. Pharm. Sci., 73, 407-408 (1984).
6. Dye, C., Williams, B. G., Espinal, M. A., and Raviglions, M. C., Erasing the Worlds Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis. Science, 295, 2042-2046 (2002).
7. Dye, C. and Williams, B. G., Criteria for the control of drug-resistant tuberculosis. Proc. Nati. Acad. Sci. USA, 97, 8180-8185 (2000).
8. Ehud, K., Margalith, E., and Winer, B., Structure activity relations of thiosemicarbazones on vaccinia virus and IBT-dependent mutant. J. Antimicrob. Chemotherap., 2, 255-260 (1976).
9. El-Sebai, A. I., Soliman, R., and Rida, S. M., Synthesis of some new acid hydrazides structurally related to certain tuberculostatic agents. Egypt. J. Pharm. Sci., 14, 67-73 (1973).
10. Knotz, F., Production of antiviral and antimicrobial substances. 1. 1-Alkylisatin-3-acylhydrazones. Scientia Pharmaceutica, 38, 98-106 (1970).
11. oct from structures. Chem. Rev., 93, 1281-1306 (1993).
12. Mahfouz, N. M., Omar, F. A., and Aboul-Fadl, T., Cyclic amide derivatives as potential prodrugs: N-hydroxymethylsuccinimide-/isatin esters of some NSAIDs as chemical delivery system with improved therapeutic index. Eur. J. Med. Chem., 34, 551-562 (1999).
13. Majumdar, K. C., Kundu, A. K., and Chatterjee, P., 1-Alkylisatins via aldol-retro-aldol condensation. J. Chem. Research (S), 460-461 (1996).
14. th Ed., Pregamon press, New York , p.1147 (1991).
15. Møss, J. and Bundgaard, H., Prodrugs of peptides. 7. Transdermal delivery of thyrotropin-releasing hormone (TRH) via prodrugs. Inter. J. Pharm., 66, 39-45 (1990).
16. NIAZI S., In "Textbook of Biopharmaceutics and Clinical Pharmacokinetics, Appleton-Century-Crofts, New York, p. 151 (1992).
17. Pablos-Mendez, A., Gowda, D. K., and Frieden, T. R., Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Bull World Health Organ, 80, 489-495 (2002).
18. Petrini, B. and Hoffiner, S., Drug-resistant and multidrugresistant tubercle bacilli. International Journal of Antimicrobial Agents, 13, 293-97 (1999).
19. Piscopo, B., Diumo, M. V., Godliardi, R., Cucciniello, M., and Veneruso, G., Studies on heterocyclic compounds Indole-2,3-dione derivatives variously substituted hydrazones with antimicrobial activity. Bol. Soc. Ital. Biol. Sper., 63, 827-830 (1987).
20. Radul, O. M., Zhungietu, G. I., Rekhter, M. A., and Bukhanyuk, S. M., Simple method for the synthesis of 1-substituted isatins. Khimiya Geterotsiklicheskikh Soedinenii, 3, 353-355 (1983)
21. Selvam, P., Chandramohan, M., De Clercq, E., Witvrouw, M., and Pannecouque, C., Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3 H-indol-3-ylidene)-amino]-N(4,6-dimethyl-2-pyrimidinyl)-benzenesulfonamide and its derivatives. European Journal of Pharmaceutical Sciences, 14, 313-316 (2001).
22. Seydel, J. K. and Schaper, K.J., The problem of resistance in the treatment of Mycobacterium infections: new experimental results and combinations for the treatment of tuberculosis and leprosy. Pharmazie in unserer Zeit, 24, 313 (1995).
23. Shargel, L. and Andrew, B. C. In Applied Biopharmaceutics and Pharmaceutics, 3rd. Ed., Prentice-Hall International Co., Appleton & Lange, London, p. 174 (1993).
24. Silva, J. F. M. D., Garden, S. J., and Pinto, A. C., The Chemistry of Isatins: a Review from 1975 to 1999, J. Braz. Chem. Soc., 12, 273-324 (2001).
25. Somogyi, L. Transformation of Isatin 3-acylhydrazones under acetylating conditions: synthesis and structure elucidation of 1,5-disubstituted 3-acetylspiro[oxindole-3,2-[1,3,4]oxadiazolines]. Bull. Chem. Soc. Jpn., 74, 873-881 (2001).
26. Tomioka, H., Prospects for development of new antituberculous drugs. Kekkaku, 77, 573-584 (2002).